Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTO Rescinds Regs Reviled By Pharma, But Rule-Making Battle Continues

Executive Summary

While biotech and pharma companies continue to face myriad patent battles they have one less worry now that the U.S. Patent and Trademark Office has dropped its controversial rules to limit the number of patent claims and continuation filings an applicant may submit

You may also be interested in...



Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation

Patent owners will be better able to protect themselves from allegations they misled the Patent and Trademark Office under the Senate's revised patent reform bill

Patent Reform Bill In Senate Could Reduce "Inequitable Conduct" Litigation

Patent owners will be better able to protect themselves from allegations they misled the Patent and Trademark Office under the Senate's revised patent reform bill

Patent Reform Bill Negotiations Accelerate; Hatch Wants No-Fault Re-Issues

While patent reform legislation has been out of the spotlight for the past six months, legislators have been revising the Senate bill to win support from their colleagues. They specifically have focused on modifying the provision on post-grant review of patents and adding a provision on inequitable conduct

Related Content

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel